Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescents

Abstract

Administration of posaconazole DRTs to paediatric patients guided by a population pharmacokinetic-derived dosing algorithm resulted in predictable and potentially effective exposures and was well tolerated over prolonged time periods.